Delhi: AIIMS to start screening children for Covaxin trials from today

The All India Institute of Medical Sciences (AIIMS) in Delhi will begin screening of children aged 2 to 18 years for Covaxin clinical trials from today. Covaxin is indigenously developed anti-Covid vaccine. It is developed by Hyderabad-based biotechnology company Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

from IndiaTV: Google News Feed https://ift.tt/3wVUpyy